Aortic insufficiency medical management

Revision as of 15:36, 18 March 2011 by Lakshmi Gopalakrishnan (talk | contribs) (New page: {{SI}} {{CMG}} '''Associate Editor-In-Chief:''' {{CZ}}; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S. {{Editor Help}} Medical therapy of chronic aortic insufficiency ...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Aortic insufficiency medical management

Articles

Most recent articles on Aortic insufficiency medical management

Most cited articles on Aortic insufficiency medical management

Review articles on Aortic insufficiency medical management

Articles on Aortic insufficiency medical management in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Aortic insufficiency medical management

Images of Aortic insufficiency medical management

Photos of Aortic insufficiency medical management

Podcasts & MP3s on Aortic insufficiency medical management

Videos on Aortic insufficiency medical management

Evidence Based Medicine

Cochrane Collaboration on Aortic insufficiency medical management

Bandolier on Aortic insufficiency medical management

TRIP on Aortic insufficiency medical management

Clinical Trials

Ongoing Trials on Aortic insufficiency medical management at Clinical Trials.gov

Trial results on Aortic insufficiency medical management

Clinical Trials on Aortic insufficiency medical management at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Aortic insufficiency medical management

NICE Guidance on Aortic insufficiency medical management

NHS PRODIGY Guidance

FDA on Aortic insufficiency medical management

CDC on Aortic insufficiency medical management

Books

Books on Aortic insufficiency medical management

News

Aortic insufficiency medical management in the news

Be alerted to news on Aortic insufficiency medical management

News trends on Aortic insufficiency medical management

Commentary

Blogs on Aortic insufficiency medical management

Definitions

Definitions of Aortic insufficiency medical management

Patient Resources / Community

Patient resources on Aortic insufficiency medical management

Discussion groups on Aortic insufficiency medical management

Patient Handouts on Aortic insufficiency medical management

Directions to Hospitals Treating Aortic insufficiency medical management

Risk calculators and risk factors for Aortic insufficiency medical management

Healthcare Provider Resources

Symptoms of Aortic insufficiency medical management

Causes & Risk Factors for Aortic insufficiency medical management

Diagnostic studies for Aortic insufficiency medical management

Treatment of Aortic insufficiency medical management

Continuing Medical Education (CME)

CME Programs on Aortic insufficiency medical management

International

Aortic insufficiency medical management en Espanol

Aortic insufficiency medical management en Francais

Business

Aortic insufficiency medical management in the Marketplace

Patents on Aortic insufficiency medical management

Experimental / Informatics

List of terms related to Aortic insufficiency medical management

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Medical therapy of chronic aortic insufficiency involves the use of vasodilators. Small trials have shown a short term benefit in the use of ACE inhibitors, nifedipine, and hydralazine in improving left ventricular wall stress, ejection fraction, and mass. The use of these vasodilators is only indicated in individuals who suffer from hypertension in addition to AI. The goal in using these pharmacologic agents is to decrease the afterload so that the left ventricle is somewhat spared. The regurgitant fraction may not change significantly, since the gradient between the aortic and left ventricular pressures is usually fairly low at the initiation of treatment.

References

Template:WH Template:WS